Enhanced fibronectin expression is associated with the development of graft arteriosclerosis in human renal allografts.
Tanabe
S
S
Department of Urology, Osaka City University Medical School, Japan.
Ueda
M
M
Han
Y S
YS
Nakatani
T
T
Kishimoto
T
T
Suzuki
S
S
Amemiya
H
H
D000199:Actins / Q000032:analysis; D000328:Adult; D000911:Antibodies, Monoclonal; D001161:Arteriosclerosis / Q000473:pathology*; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D005260:Female; D005353:Fibronectins / Q000032:analysis* / Q000096:biosynthesis; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D006435:Renal Dialysis; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D013997:Time Factors; D014184:Transplantation, Homologous; D014746:Vimentin / Q000032:analysis; D014841:von Willebrand Factor / Q000032:analysis
D000199:Actins; D000911:Antibodies, Monoclonal; D005353:Fibronectins; D014746:Vimentin; D014841:von Willebrand Factor